April 20,2023
- July 29, 2020 - Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional). See NOFO PAR-20-255.
- April 20, 2023 - Notice to Extend the Expiration Date of PAR-20-254: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional). See Notice NOT-HG-23-036.
- April 20, 2023 - Notice to Extend the Expiration Date of PAR-20-257: Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional). See Notice NOT-HG-23-038.
National Human Genome Research Institute (NHGRI)
The purpose of this notice is to extend the expiration date for PAR-20-255 - PAR-20-255: Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) by one review cycle..
An additional receipt date has been added, October 19, 2023, for new applications and November 17, 2023, for resubmission and revision applications. This Notice of Funding Opportunity now expires on November 18, 2023. The changes below are in bold italics.
The Notice of Funding Opportunity currently reads as:
Part 1. Overview Information, Key Dates
Application Due Date(s):
New Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023
Resubmission and Revision Due Dates: November 17, 2020, March 17, 2021, July 19, 2021, November 17, 2021, March 17, 2022, July 19, 2022, November 17, 2022, March 17, 2023, July 19, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Applications: Not Allowed
Scientific Merit Review: Standard dates apply
Advisory Council Review: Standard dates apply
Earliest Start Date: Standard dates apply
Expiration Date: July 20, 2023
The Notice of Funding Opportunity has been modified as follows:
Part 1. Overview Information, Key Dates
Application Due Date(s):
New Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023, October 19, 2023
Resubmission and Revision Due Dates: November 17, 2020, March 17, 2021, July 19, 2021, November 17, 2021, March 17, 2022, July 19, 2022, November 17, 2022, March 17, 2023, July 19, 2023, November 17, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Applications: Not Allowed
Scientific Merit Review: Standard dates apply
Advisory Council Review: Standard dates apply
Earliest Start Date: Standard dates apply
Expiration Date: November 18, 2023
All other aspects of this NOFO remain the same.
Dave Kaufman, Ph.D
National Human Genome Research Institute (NHGRI)
Telephone: 301-594-6907
Email: [email protected]
and Human Services (HHS)
